This is a trailblazing time for leaders within the pharmaceutical industry to be involved at the forefront of an important global initiative impacting our industry.
Tampa, Florida (PRWEB) November 09, 2015
International Society for Pharmaceutical Engineering (ISPE) announced at its Annual Meeting in Philadelphia, Pennsylvania, USA, the development of a tool that provides a structured approach for industry to develop strategies and practices for each of the six drug shortage dimensions, and employs a holistic approach to identifying potential vulnerabilities within the industry and supply chains.
The ISPE Drug Shortage Assessment and Prevention Tool will aide manufacturers in locating gaps between their current operations and the desired state of a reliable supply of quality pharmaceuticals. The Tool is a self-assessment process that facilitates improvements across supply chains and increases supply reliability in these six areas:
1. Building Capability
2. Corporate Culture
3. Business Continuity Planning
4. Robust Quality Systems
6. Communication with Regulatory Authorities
This Tool will enable companies to address supply chain risks with a common framework, no matter their size, capability or location.
The ISPE Drug Shortage Assessment and Prevention Tool, developed by the ISPE Drug Shortages Task Team, builds on the best practices described in the ISPE Drug Shortages Prevention Plan published by ISPE in 2014. The Task Team has assembled a holistic contribution to support a better understanding of industry and supply partner weaknesses, and provide concrete steps to put continuous improvement plans into action.
“This is a trailblazing time for leaders within the pharmaceutical industry to be involved at the forefront of an important global initiative impacting our industry,” said ISPE President and CEO John Bournas. “I am confident the ISPE Drug Shortage Assessment and Prevention Tool will make an immediate and tangible impact on the way companies handle their day-to-day activities.”
The ISPE Drug Shortage Assessment and Prevention Tool training will roll-out in phases through-out 2016, kicking off with introductory webinars in the first quarter. The next phase will include a 2-day classroom training experience and the final phase will launch on-demand training classes online.
For more information and to download the ISPE Drug Shortage Assessment and Prevention Tool, please visit http://www.ISPE.org/Drug-Shortages-Initiative.
ISPE, the International Society for Pharmaceutical Engineering, is the world’s largest not-for-profit association serving its Members through leading scientific, technical and regulatory advancement throughout the pharmaceutical lifecycle. The 20,000 Members of ISPE are building solutions in the development and manufacture of safe and effective pharmaceutical and biologic medicines and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has headquarter offices in Tampa, Florida and Bethesda, Maryland USA. Visit: http://www.ISPE.org for more information.
For more information contact:
Senior Director, Marketing Communications, ISPE
Tel: +1-813-960-2105, ext. 404